The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 633.50
Bid: 633.50
Ask: 634.50
Change: -0.50 (-0.08%)
Spread: 1.00 (0.158%)
Open: 625.00
High: 637.00
Low: 625.00
Prev. Close: 634.00
TATE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

9 May 2019 11:00

RNS Number : 5090Y
Tate & Lyle PLC
09 May 2019
 

9 May 2019

 

Tate & Lyle PLC

 

 

BOARD CHANGES

 

Tate & Lyle PLC (the "Company") announces that Kimberly (Kim) Nelson will join the Board as a non-executive director and a member of the Audit and Nominations Committees on 1 July 2019. Kim brings extensive experience and knowledge of the food and beverage industry to the Board having worked for General Mills Inc. for nearly 30 years. During her career at General Mills, she held a number of senior brand and general management roles before becoming Senior Vice President, External Relations in 2010. Kim retired from General Mills Inc. in 2018. She is a US citizen.

 

The following changes to the Board and Board Committees will take effect at the conclusion of the Company's AGM on 25 July 2019:

 

Board

· Douglas Hurt will retire from the Board, having served as a non-executive director since March 2010, as the Chair of the Audit Committee since March 2015 and as Senior Independent Director since January 2017.

· Warren Tucker is appointed as Chair of the Audit Committee.

· Paul Forman is appointed as Senior Independent Director.

 

Board Committees

· Dr Ajai Puri will step down from the Remuneration Committee and join the Audit Committee.

· Sybella Stanley will step down from the Audit Committee and join the Remuneration Committee.

· Paul Forman will step down from the Remuneration Committee.

 

Dr Gerry Murphy, Chairman of Tate & Lyle, said: "I am delighted that Kim has agreed to join the Board. Her appointment recognises the importance of the US to Tate & Lyle, in terms of our customers, operations and employees. Her substantial experience in the food and beverage industry will be of significant benefit to the Board."

 

"I would like to thank Douglas Hurt for his nine years of outstanding service and significant contribution to the Board and, in particular, for his time served as Chairman of the Audit Committee and as Senior Independent Director."

 

There are no further disclosures to be made in connection with Ms Nelson's appointment pursuant to paragraph 9.6.13 of the Financial Conduct Authority's Listing Rules.

 

 

For more information contact Tate & Lyle PLC:

Christopher Marsh, Group VP, Investor Relations

Tel: +44 (0) 20 7257 2110 or Mobile: +44 (0) 7796 192 688

 

Andrew Lorenz (FTI Consulting), Media Relations

Tel: +44 (0) 20 7269 7113 or Mobile: +44 (0) 7775 641 807

 

 

About Tate & Lyle: Tate & Lyle is a global provider of solutions and ingredients for food, beverage and industrial markets.Tate & Lyle operates through two global divisions, Food & Beverage Solutions and Primary Products, supported by the Innovation and Commercial Development and Global Operations teams. Food & Beverage Solutions is focused on growth by building leading positions globally in the categories of beverages, dairy, and soups, sauces and dressings. Primary Products is focused on delivering steady earnings and generating cash.Food & Beverage Solutions consists of: Texturants, including speciality starches; Sweeteners, including low- and no-calorie sweeteners; and a Health and Wellness portfolio comprising mainly speciality fibres; and Stabilisers and Functional Systems, which are bespoke ingredient blends that ensure foods retain their structure.Primary Products consists of high-volume sweeteners, industrial starches and fermentation products (primarily acidulants). It also sells co-products from the corn milling process as animal nutrition.Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2018, Tate & Lyle sales totalled £2.7 billion. For more information, please visit http://www.tateandlyle.com

 

 

Claire-Marie O'Grady

Company Secretary

Tate & Lyle PLC

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOASSASUUFUSESI
Date   Source Headline
4th Jan 20172:11 pmBUSDirector/PDMR Shareholding
4th Jan 201712:51 pmBUSBlock Listing Interim Review
15th Dec 20167:00 amBUSDirectorate change
1st Dec 20162:27 pmBUSTotal Voting Rights
30th Nov 20162:09 pmBUSAdditional Listing
23rd Nov 201610:06 amBUSDirector/PDMR Shareholding
10th Nov 20169:56 amBUSDirector/PDMR Shareholding
3rd Nov 20167:00 amBUSHalf-year Report
1st Nov 20164:34 pmBUSTotal Voting Rights
31st Oct 201610:23 amBUSDirector Declaration
26th Oct 201610:17 amBUSDirectorate Change
10th Oct 20169:44 amBUSDirector Declaration
3rd Oct 201610:34 amBUSTotal Voting Rights
1st Sep 201610:06 amBUSTotal Voting Rights
22nd Aug 20162:12 pmBUSDirector/PDMR Shareholding
12th Aug 201610:11 amBUSDirector/PDMR Shareholding
5th Aug 20163:20 pmBUSHolding(s) in Company
2nd Aug 20161:48 pmBUSDirector/PDMR Shareholding
1st Aug 20162:26 pmBUSTotal Voting Rights
27th Jul 20163:39 pmBUSDirector/PDMR Shareholding
26th Jul 201611:22 amBUSDirector/PDMR Shareholding
21st Jul 20164:52 pmBUSResult of AGM
21st Jul 20167:00 amBUSTrading Statement
1st Jul 20165:29 pmBUSBlock listing Interim Review
1st Jul 20163:37 pmBUSTotal Voting Rights
29th Jun 201611:44 amBUSDirector/PDMR Shareholding
28th Jun 201610:51 amBUSDirector/PDMR Shareholding
22nd Jun 20161:49 pmBUSDirector/PDMR Shareholding
20th Jun 20164:40 pmBUSAnnual Financial Report
17th Jun 201611:52 amBUSHolding(s) in Company
16th Jun 20164:40 pmBUSDirector/PDMR Shareholding
1st Jun 201610:17 amBUSTotal Voting Rights
26th May 20167:00 amBUSFinal Results
3rd May 20163:20 pmBUSHolding(s) in Company
5th Apr 20167:00 amBUSTrading Statement
1st Apr 20169:32 amBUSTotal Voting Rights
11th Mar 201610:00 amBUSDirectorate Change
2nd Mar 201611:37 amBUSDirector/PDMR Shareholding
12th Feb 20164:27 pmBUSDirector/PDMR Shareholding
11th Feb 20164:48 pmBUSDirector/PDMR Shareholding
11th Feb 20167:00 amBUSTrading Statement
14th Jan 20167:00 amBUSTate & Lyle Capital Markets Event
8th Jan 201611:51 amBUSDirector/PDMR Shareholding
5th Jan 20163:31 pmBUSDirector/PDMR Shareholding
4th Jan 20169:56 amBUSBlocklisting Interim Review
11th Dec 201511:49 amBUSDirector/PDMR Shareholding
4th Dec 201510:48 amBUSDirector/PDMR Shareholding
2nd Dec 201510:28 amBUSHolding(s) in Company
1st Dec 201510:17 amBUSTotal Voting Rights
9th Nov 20152:41 pmBUSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.